Real-World Ravulizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

被引：0
|
作者：
Cheng, Wendy Y. [1 ]
Fishman, Jesse [2 ]
Sarda, Sujata P. [2 ]
Krishnan, Sangeeta [2 ]
Kunzweiler, Colin [1 ]
Vu, Jensen Duy [1 ]
Yenikomshian, Mihran [1 ]
Duh, Mei Sheng [1 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Apellis Pharmaceut Inc, Waltham, MA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4999
引用
收藏
页数：4
相关论文
共 50 条
  • [41] COST-UTILITY ANALYSIS OF RAVULIZUMAB COMPARED WITH ECULIZUMAB IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    OConnell, T.
    Buessing, M. G.
    Johnson, S. J.
    Tu, L.
    Tomazos, I
    Thomas, S. K.
    VALUE IN HEALTH, 2019, 22 : S341 - S341
  • [42] Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
    O'Connell, Thomas
    Buessing, Marric
    Johnson, Scott
    Tu, Lufei
    Thomas, Simu K.
    Tomazos, Ioannis
    PHARMACOECONOMICS, 2020, 38 (09) : 981 - 994
  • [43] Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
    Tomazos, Ioannis
    Sierra, J. Rafael
    Johnston, Karissa M.
    Cheung, Antoinette
    Brodsky, Robert A.
    Weitz, Ilene C.
    HEMATOLOGY, 2020, 25 (01) : 327 - 334
  • [44] Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naive Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada
    Panse, Jens
    Llamas, Juan Carlos Vallejo
    Wilson, Koo
    Hakimi, Zalmai
    Czech, Barbara
    Kerr, Brianne
    Williamson, Sam
    Garratt-Wheeldon, Jade
    Taylor, Yasmin
    Hatchell, Niall
    Patriquin, Christopher
    BLOOD, 2024, 144 : 5085 - 5086
  • [45] Development of APPRISE-PNH: A Patient Platform for Real-World Data on Iptacopan in the United States for Patients With Paroxysmal Nocturnal Hemoglobinuria
    Dingli, David
    Yen, Glorian
    Kuypers, Nicholas
    Paulose, Jincy
    Chanpura, Mohin
    Lee, Soyon
    Barone, Joseph
    Buchan, Tayler
    Buchan, Claire
    Tang, Jackson
    Waheed, Anem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S399 - S400
  • [46] Patterns of topiramate utilization among Medicaid patients: Diagnosis, comorbidities and real-world dosing
    Poston, S
    Rupnow, M
    Dickson, M
    Johnsrud, M
    Gdovin, JM
    Bramley, T
    Armstrong, RB
    VALUE IN HEALTH, 2006, 9 (03) : A86 - A86
  • [47] Efficacy and Safety of Concomitant Use of Ravulizumab and IST in Patients with Paroxysmal Nocturnal Hemoglobinuria up to 52 Weeks
    Schrezenmeier, H.
    Gandhi, S.
    Lee, J. W.
    Hill, A.
    Ptushkin, V.
    Pessoa, V.
    Notaro, R.
    Wang, J.
    Ogawa, M.
    Okamoto, S.
    Lee, L. W. Lee
    de Latour, R. Peffault
    Kulasekararaj, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 200 - 201
  • [48] EARLY HEMOGLOBIN AND QUALITY-OF-LIFE TRENDS FROM OPERA: A REAL-WORLD STUDY OF PEGCETACOPLAN TREATMENT IN US ADULTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Fishman, J.
    Min, J.
    Arnett, L.
    Shenoy, A.
    VALUE IN HEALTH, 2023, 26 (06) : S20 - S20
  • [49] Efficacy and Safety of Concomitant Use of Ravulizumab and IST in Patients with Paroxysmal Nocturnal Hemoglobinuria up to 52 Weeks
    Schrezenmeier, Hubert
    Lee, Jong Wook
    Hill, Anita
    Ptushkin, Vadim V.
    Pessoa, Viviani
    Notaro, Rosario
    Wang, Jimmy
    Ogawa, Masayo
    Okamoto, Shinichiro
    Wong, Lily L. L.
    De latour, Regis Peffault
    Kulasekararaj, Austin
    BLOOD, 2020, 136
  • [50] Real-World Adherence with Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria Compared with Previously Reported Oral Medication Adherence Rates
    Dingli, David
    Mulherin, Brian
    Hillmen, Peter
    Czech, Barbara
    Panse, Jens
    BLOOD, 2024, 144 : 5680 - 5681
12345